O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
601
ADMA Biologics
ADMA
$4.04B
| $16.91 | $7 |
59%
downside
| Outperform | 5 years ago |
|
|
602
Wyndham Hotels & Resorts
WH
$6.58B
| $86.21 | $55 |
36%
downside
| Outperform | 5 years ago |
|
|
603
Visa
V
$681B
|
GG
Glenn Greene
| $350.99 | $190 |
46%
downside
| Outperform | 5 years ago |
|
604
Jazz Pharmaceuticals
JAZZ
$7.77B
| $128.02 | $141 |
10%
upside
| Outperform | 5 years ago |
|
|
605
CarGurus
CARG
$3.59B
| $36.18 | $24 |
34%
downside
| Outperform | 5 years ago |
|
|
606
SLR Investment Corp
SLRC
$911M
|
AT
Allison Taylor
| $16.69 | $19 |
14%
upside
| Outperform | 5 years ago |
|
607
New Mountain Finance
NMFC
$1.13B
|
CK
Chris Kotowski
| $10.64 | $11 |
3%
upside
| Outperform | 5 years ago |
|
608
Ares Capital
ARCC
$15.8B
|
CK
Chris Kotowski
| $22.37 | $16 |
28%
downside
| Outperform | 5 years ago |
|
609
Varonis Systems
VRNS
$6.24B
|
SE
Shaul Eyal
| $55.73 | $23.33 |
58%
downside
| Outperform | 5 years ago |
|
610
Biohaven
BHVN
$1.7B
|
ER
Esther Rajavelu
| $16.07 | $37 |
130%
upside
| Perform | 5 years ago |
|
611
Apple
AAPL
$3.56T
|
AU
Andrew Uerkwitz
| $239.78 | $20 |
92%
downside
| Outperform | 5 years ago |
|
612
Apellis Pharmaceuticals
APLS
$3.62B
| $28.65 | $62 |
116%
upside
| Outperform | 5 years ago |
|